October 25, 2021

The World Stock Markets Tips & Targets, News, Views & Updates

The World Stock Markets Tips & Targets, News, Views & Updates

: DICE Therapeutics started at outperform with $60 stock price target at Evercore ISI

DICE Therapeutics Inc.

DiCE Therapeutics, Inc. is a biopharmaceutical company. It designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA.

Share This :